HK1116995A1 - Secretory cell-containing macrobeads comprising seakem gold agarose, and uses thereof - Google Patents
Secretory cell-containing macrobeads comprising seakem gold agarose, and uses thereofInfo
- Publication number
- HK1116995A1 HK1116995A1 HK08112053.1A HK08112053A HK1116995A1 HK 1116995 A1 HK1116995 A1 HK 1116995A1 HK 08112053 A HK08112053 A HK 08112053A HK 1116995 A1 HK1116995 A1 HK 1116995A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- agarose
- less
- secretory cell
- content
- concentration
- Prior art date
Links
- 229920000936 Agarose Polymers 0.000 title abstract 5
- 210000002955 secretory cell Anatomy 0.000 title abstract 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 title 1
- 239000010931 gold Substances 0.000 title 1
- 229910052737 gold Inorganic materials 0.000 title 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 239000011324 bead Substances 0.000 abstract 2
- 239000000499 gel Substances 0.000 abstract 2
- 230000004568 DNA-binding Effects 0.000 abstract 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- 239000008351 acetate buffer Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
- C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
- A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/70—Polysaccharides
- C12N2533/76—Agarose, agar-agar
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Environmental Sciences (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Plant Pathology (AREA)
- Mycology (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Obesity (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72091705P | 2005-09-26 | 2005-09-26 | |
| PCT/US2006/036125 WO2007038029A2 (fr) | 2005-09-26 | 2006-09-14 | Macro-perles contenant des cellules sécrétoires comprenant de l'agarose seakem gold et leurs utilisations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1116995A1 true HK1116995A1 (en) | 2009-01-09 |
Family
ID=37900243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK08112053.1A HK1116995A1 (en) | 2005-09-26 | 2008-11-04 | Secretory cell-containing macrobeads comprising seakem gold agarose, and uses thereof |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8518394B2 (fr) |
| EP (1) | EP1928249B1 (fr) |
| JP (1) | JP4937265B2 (fr) |
| KR (1) | KR101110386B1 (fr) |
| CN (1) | CN101272690B (fr) |
| AT (1) | ATE547004T1 (fr) |
| AU (1) | AU2006295114B2 (fr) |
| CA (1) | CA2622529C (fr) |
| DK (1) | DK1928249T3 (fr) |
| ES (1) | ES2379008T3 (fr) |
| HK (1) | HK1116995A1 (fr) |
| IL (1) | IL190028A (fr) |
| NO (1) | NO341154B1 (fr) |
| NZ (1) | NZ566621A (fr) |
| PL (1) | PL1928249T3 (fr) |
| PT (1) | PT1928249E (fr) |
| RU (1) | RU2417090C2 (fr) |
| WO (1) | WO2007038029A2 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012071394A1 (fr) | 2010-11-23 | 2012-05-31 | The Rogosin Institute, Inc. | Méthode pour isoler une cellule cancéreuse résistant aux agents chimiothérapeutiques et présentant des propriétés similaires à celles des cellules souches |
| BR112014015804B1 (pt) * | 2012-01-31 | 2022-10-18 | The Rogosin Institute, Inc | Método para produzir uma composição de matéria |
| US9555007B2 (en) * | 2013-03-14 | 2017-01-31 | Massachusetts Institute Of Technology | Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5441878A (en) * | 1987-12-08 | 1995-08-15 | Thies Technology, Inc. | Preparation of uniform droplets by using gas pressure to force liquid from a syringe and flowing gas to detach droplets |
| US5053332A (en) * | 1989-07-24 | 1991-10-01 | Cook Richard B | Agarose beads, preferably incorporating biological materials |
| US4983268A (en) | 1989-08-03 | 1991-01-08 | Fmc Corporation | High gel strength low electroendosmosis agarose |
| AU673848B2 (en) * | 1992-07-23 | 1996-11-28 | Fmc Corporation | Glucomannan spongeous matrices |
| ATE320482T1 (de) | 1994-01-13 | 2006-04-15 | Rogosin Inst | Makroeingekapselte sekretorische zellen |
| US5651980A (en) * | 1994-04-15 | 1997-07-29 | Biohybrid Technologies, Inc. | Methods of use of uncoated gel particles |
| US6224912B1 (en) | 1996-04-03 | 2001-05-01 | The Rogo Institute | Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment |
| US6303151B1 (en) | 1996-04-03 | 2001-10-16 | The Rogosin Institute | Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment |
| US5888497A (en) | 1996-04-03 | 1999-03-30 | The Rogosin Institute | Agarose coated agarose beads containing cancer cells that produce material which suppresses cancer cell proliferation |
| US7128931B2 (en) * | 2003-10-17 | 2006-10-31 | Francois Leblond | Semi-permeable microcapsule with covalently linked layers and method for producing same |
| US6997864B2 (en) | 2003-11-03 | 2006-02-14 | Otologics, Llc | Method for obtaining diagnostic information relating to a patient having an implanted transducer |
| JP4704439B2 (ja) * | 2004-11-17 | 2011-06-15 | ザ・ロゴシン・インスティテュート | 島単離に対する膵臓の適合性を決定するための評価方法 |
-
2006
- 2006-09-14 AT AT06803714T patent/ATE547004T1/de active
- 2006-09-14 PL PL06803714T patent/PL1928249T3/pl unknown
- 2006-09-14 US US11/521,977 patent/US8518394B2/en active Active
- 2006-09-14 WO PCT/US2006/036125 patent/WO2007038029A2/fr active Application Filing
- 2006-09-14 DK DK06803714.2T patent/DK1928249T3/da active
- 2006-09-14 PT PT06803714T patent/PT1928249E/pt unknown
- 2006-09-14 CN CN2006800352377A patent/CN101272690B/zh not_active Expired - Fee Related
- 2006-09-14 ES ES06803714T patent/ES2379008T3/es active Active
- 2006-09-14 CA CA2622529A patent/CA2622529C/fr active Active
- 2006-09-14 AU AU2006295114A patent/AU2006295114B2/en not_active Ceased
- 2006-09-14 NZ NZ566621A patent/NZ566621A/en not_active IP Right Cessation
- 2006-09-14 EP EP06803714A patent/EP1928249B1/fr active Active
- 2006-09-14 RU RU2008114920/15A patent/RU2417090C2/ru active
- 2006-09-14 KR KR1020087007337A patent/KR101110386B1/ko active IP Right Grant
- 2006-09-14 JP JP2008532295A patent/JP4937265B2/ja not_active Expired - Fee Related
-
2008
- 2008-03-09 IL IL190028A patent/IL190028A/en active IP Right Grant
- 2008-03-10 NO NO20081232A patent/NO341154B1/no not_active IP Right Cessation
- 2008-11-04 HK HK08112053.1A patent/HK1116995A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE547004T1 (de) | 2012-03-15 |
| EP1928249B1 (fr) | 2012-02-29 |
| PT1928249E (pt) | 2012-05-25 |
| NO341154B1 (no) | 2017-09-04 |
| US8518394B2 (en) | 2013-08-27 |
| AU2006295114A1 (en) | 2007-04-05 |
| EP1928249A4 (fr) | 2010-04-07 |
| EP1928249A2 (fr) | 2008-06-11 |
| PL1928249T3 (pl) | 2012-11-30 |
| DK1928249T3 (da) | 2012-06-18 |
| AU2006295114B2 (en) | 2010-01-28 |
| CA2622529C (fr) | 2014-02-18 |
| JP4937265B2 (ja) | 2012-05-23 |
| RU2008114920A (ru) | 2009-11-10 |
| JP2009509507A (ja) | 2009-03-12 |
| NO20081232L (no) | 2008-04-23 |
| KR20080071122A (ko) | 2008-08-01 |
| WO2007038029A3 (fr) | 2007-09-20 |
| ES2379008T3 (es) | 2012-04-19 |
| CN101272690A (zh) | 2008-09-24 |
| KR101110386B1 (ko) | 2012-03-08 |
| WO2007038029A2 (fr) | 2007-04-05 |
| US20070071732A1 (en) | 2007-03-29 |
| CA2622529A1 (fr) | 2007-04-05 |
| IL190028A0 (en) | 2008-08-07 |
| CN101272690B (zh) | 2012-08-29 |
| IL190028A (en) | 2014-12-31 |
| RU2417090C2 (ru) | 2011-04-27 |
| NZ566621A (en) | 2010-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE419629T1 (de) | Poröse ferro- oder ferrimagnetische glasteilchen für molekültrennung | |
| BRPI0514680A (pt) | produção de anticorpos anti-amilóide beta | |
| WO2004061080A3 (fr) | Polypeptides lies au stress et utilisation desdits polypeptides | |
| BRPI0617788A2 (pt) | processos isolados estaticamente verificáveis com comunicação interprocessos | |
| WO2007011857A3 (fr) | Oignon de jour long faiblement piquant | |
| BR0214250A (pt) | peptìdeos que promovem a aderência, crescimento e secreção da célula | |
| WO2003054515A3 (fr) | Fabrication de surfaces a adsorption proteique et/ou adhesion cellulaire reduites | |
| WO2020005846A8 (fr) | Marquage de l'adn | |
| DE60138715D1 (de) | Tnf-rezeptor-ähnliche moleküle und deren anwendungen | |
| HK1116995A1 (en) | Secretory cell-containing macrobeads comprising seakem gold agarose, and uses thereof | |
| DE60239729D1 (de) | Männliche fertilitätvermittelnde nukleotidsequenzen und deren verwendung | |
| DE50000767D1 (de) | Mit nanopartikeln modifizierte bindemittel für überzugsmittel und deren verwendung | |
| NO20062015L (no) | Anti-NIK-antistoffer og anvendelser derav | |
| BR0309279A (pt) | Macromoléculas em multicamadas e métodos para uso das mesmas | |
| WO2004046314A3 (fr) | Procedes de detection de dimethylarginine asymetrique dans un echantillon biologique | |
| WO2022039904A3 (fr) | Purification d'adn sulfoné | |
| AU2002304249A1 (en) | Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same | |
| WO2002083932A3 (fr) | Chaines de decomposition enzymatiques | |
| EP1726311A3 (fr) | Migration de cellules hématopoiétiques et de cellules précurseurs vers le foie | |
| WO2005089509A3 (fr) | Systemes d'essai a haut debit et procedes pour identifier des agents qui modifient l'expression de proteines cellulaires | |
| ATE274576T1 (de) | 2,5-diketo-d-gluconsäure-reduktasen und deren anwendungen | |
| WO2007000163A8 (fr) | Immobilisation de polypeptides par irradiation | |
| EP1921157A3 (fr) | Processus de détection de substances toxiques | |
| EP1348767A3 (fr) | Puce de polymères et procédé d'identification d'un polymère ionique | |
| PL1644579T3 (pl) | Wytwarzanie papieru z użyciem modyfikowanych zoli krzemionkowych jako mikrocząstek |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230920 |